학술논문
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Document Type
Article
Author
Harrison, S.A.; Anstee, Q.M.; Newsome, P.N.; Rudraraju, M.; Patil, R.; Noureddin, M.; Bedossa, P.; Castera, L.; Ratziu, V.; Guy, C.D.; Schattenberg, J.M.; Schiefke, I.; Loomba, R.; Taub, R.; Labriola, D.; Moussa, S.E.; Alkhouri, N.; Neff, G.W.; Baum, S.J.; Rinella, M.E.; Charlton, M.R.; Abdelmalek, M.F.; Younossi, Z.; Sanyal, A.J.; Francque, S.; Lanthier, N.; Mangia, A.; Pericàs, J.M.; Bansal, M.B.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 8 February 2024, 390(6):497-509)
Subject
Language
English
ISSN
15334406
00284793
00284793